Evidence map›Paper›PMID 28806419›Full record

Trial reportPloS one2017

Effects of short-term dry immersion on bone remodeling markers, insulin and adipokines.

Marie-Thérèse Linossier, Liubov E Amirova, Mireille Thomas, Myriam Normand, Marie-Pierre Bareille, Guillemette Gauquelin-Koch, Arnaud Beck, Marie-Claude Costes-Salon, Christine Bonneau, Claude Gharib and 2 more

2 registry-linked trialsOpen access · goldAbstract readClinical Trial
In one paragraph

Trial report in PloS one, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05043974 nacompletednot on this mapstarted 2021, after this paper: background citation

Integrative Study of Physiological Changes Induced by a 5-Day Dry Immersion, Used as a Ground-based Model to Mimic Weightlessness: a Pilot Study on 20 Healthy Female Volunteers (DI5-Women Study)

TypeinterventionalSponsorCentre National d'Etudes SpatialesRan2021 to 2021Enrolled20ConditionsWeightlessness, Weightlessness, Adverse EffectArmsDry immersion
NCT05493176 nacompletednot on this mapstarted 2022, after this paper: background citation

Standardization of the Dry Immersion Model Used as a Ground-based Model to Mimic Weightlessness. Phase 2: a 5-day Dry Immersion Study on 20 Healthy Male Volunteers (VIVALDI2)

TypeinterventionalSponsorCentre National d'Etudes SpatialesRan2022 to 2022Enrolled20ConditionsWeightlessnessArmsDry immersion
3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 37 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Resistance and Aerobic Preconditioning Delays Unloading-Induced Multisystemic Physiological Changes: The NEBULA Project.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2025
    Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Review
  9. Broad application prospects of bone turnover markers in pediatrics.Journal of clinical laboratory analysis · 2022
    Review
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Osteocytes and Weightlessness.Current osteoporosis reports · 2021
    Review
  16. Article
  17. Review
  18. Review
  19. The Interplay Between Bone and Glucose Metabolism.Frontiers in endocrinology · 2020
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 2 countries.

Marie-Thérèse LinossierUniversity of Lyon, Medicine Faculty of Saint-Etienne, INSERM, UMR 1059, Saint Etienne, France.ORCID http://orcid.org/0000-0001-6718-6354
Liubov E AmirovaUniversity of Angers, Medicine Faculty, Mitovasc Laboratory, UMR CNRS 6015, INSERM 1083, Angers, France.
Mireille ThomasUniversity of Lyon, Medicine Faculty of Saint-Etienne, INSERM, UMR 1059, Saint Etienne, France.
Myriam NormandUniversity of Lyon, Medicine Faculty of Saint-Etienne, INSERM, UMR 1059, Saint Etienne, France.
Marie-Pierre BareilleInstitute of Space Physiology and Medicine (MEDES), Toulouse, France.
Guillemette Gauquelin-KochFrench Space Agency (CNES), Paris, France.
Arnaud BeckInstitute of Space Physiology and Medicine (MEDES), Toulouse, France.
Marie-Claude Costes-SalonInstitute of Space Physiology and Medicine (MEDES), Toulouse, France.
Christine BonneauUniversity Hospital, Saint-Etienne, France.
Claude GharibUniversity of Claude Bernard, Lyon, France.
Marc-Antoine CustaudUniversity of Angers, Medicine Faculty, Mitovasc Laboratory, UMR CNRS 6015, INSERM 1083, Angers, France.
Laurence VicoUniversity of Lyon, Medicine Faculty of Saint-Etienne, INSERM, UMR 1059, Saint Etienne, France.
Université Claude Bernard Lyon 1 · FRCentre National de la Recherche Scientifique · FRCentre Hospitalier Universitaire de Saint-Étienne · FREuropean Space Agency · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDry immersion (DI), a ground-based model of microgravity previously used in Russia, has been recently implemented in France. The aim of this study was to analyze early events in a short-term DI model in which all conditions are met to investigate who is first challenged from osteo- or adipo-kines and to what extent they are associated to insulin-regulating hormones.

methodsTwelve healthy men were submitted to a 3-day DI. Fasting blood was collected during pre-immersion phase for the determination of the baseline data collection (BDC), daily during DI (DI24h, DI48H and DI72h), then after recovery (R+3h and R+24h). Markers of bone turnover, phosphocalcic metabolism, adipokines and associated factors were measured.

resultsBone resorption as assessed by tartrate-resistant acid phosphatase isoform 5b and N-terminal crosslinked telopeptide of type I collagen levels increased as early as DI24h. At the same time, total procollagen type I N- and C-terminal propeptides and osteoprotegerin, representing bone formation markers, decreased. Total osteocalcin [OC] was unaffected, but its undercarboxylated form [Glu-OC] increased from DI24h to R+3h. The early and progressive increase in bone alkaline phosphatase activities suggested an increased mineralization. Dickkopf-1 and sclerostin, as negative regulators of the Wnt-β catenin pathway, were unaltered. No change was observed either in phosphocalcic homeostasis (calcium and phosphate serum levels, 25-hydroxyvitamin D, fibroblast growth factor 23 [FGF23]) or in inflammatory response. Adiponectemia was unchanged, whereas circulating leptin concentrations increased. Neutrophil gelatinase-associated lipocalin [lipocalin-2], a potential regulator of bone homeostasis, was found elevated by 16% at R+3h compared to DI24h. The secretory form of nicotinamide phosphoribosyl-transferase [visfatin] concentrations almost doubled after one day of DI and remained elevated. Serum insulin-like growth factor 1 levels progressively increased. Fasting insulin concentrations increased during the entire DI, whereas fasting glucose levels tended to be higher only at DI24h and then returned to BDC values. Changes in bone resorption parameters negatively correlated with changes in bone formation parameters. Percent changes of ultra-sensitive C-reactive protein positively correlated with changes in osteopontin, lipocalin-2 and fasting glucose. Furthermore, a positive correlation was found between changes in FGF23 and Glu-OC, the two main osteoblast-/osteocyte-derived hormones.

conclusionOur results demonstrated that DI induced an unbalanced remodeling activity and the onset of insulin resistance. This metabolic adaptation was concomitant with higher levels of Glu-OC. This finding confirms the role of bone as an endocrine organ in humans. Furthermore, visfatin for which a great responsiveness was observed could represent an early and sensitive marker of unloading in humans.

Indexed as

Bone RemodelingImmersionAdipokinesAdultBiomarkersBody WeightBone and BonesBone ResorptionEnergy MetabolismFibroblast Growth Factor-23HormonesHumansInsulinMaleMetabolic Networks and PathwaysOsteogenesisAdipokinesBiomarkersFGF23 protein, humanFibroblast Growth Factor-23HormonesInsulin

Identifiers

PMID28806419
PMCPMC5555617
OpenAlexW2746783896

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.